SCHEDULE: Vanguard Discloses Stake in Lantheus Holdings

Vanguard Portfolio Management has reported a beneficial ownership stake of 5.06% in Lantheus Holdings Inc., as of June 30, 2026.

Summary

• Vanguard Portfolio Management, along with its affiliates Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC, has disclosed a beneficial ownership of 3,300,293 shares of Lantheus Holdings Inc. common stock.
• This ownership represents 5.06% of the class of securities.
• The filing indicates that Vanguard Portfolio Management has sole dispositive power over these shares and sole voting power over 61,822 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of an institutional investor's stake and does not provide new operational or financial information about Lantheus Holdings itself.

Positives

• Vanguard's investment indicates confidence in Lantheus Holdings, potentially signaling stability and growth prospects.
• The disclosure of a significant stake by a major institutional investor can enhance market confidence in Lantheus Holdings.

Negatives

• The filing does not contain any negative financial results or operational issues.

Risks

• Potential for future changes in Vanguard's investment strategy could impact Lantheus Holdings' stock price.
• As a significant shareholder, Vanguard's voting power could influence corporate decisions.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from Lantheus Holdings. It solely reports Vanguard's ownership stake.

Management Comments

• Vanguard Portfolio Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.
• No one other person's interest in the securities reported herein is more than 5%.

Industry Context

StockSavvy.ai notes that institutional investor disclosures like this Schedule 13G are common in the healthcare and medical technology sectors, reflecting active portfolio management and strategic positioning by large asset managers.

Stakeholder Impact

• Shareholders: The disclosure may influence investor perception and potentially trading activity due to Vanguard's significant stake.
• Management of Lantheus Holdings: May need to engage with Vanguard regarding strategic decisions or governance matters.
• Market Analysts: This filing provides data for valuation models and investment recommendations.

Next Steps

• Monitor future filings from Vanguard Portfolio Management for any changes in their stake in Lantheus Holdings.
• Observe Lantheus Holdings' future financial reports and strategic announcements for performance indicators.

Key Dates

Keywords

Lantheus Holdings, Vanguard, Schedule 13G, Beneficial Ownership, Investment Management, Healthcare, Medical Devices, Shareholder